Cannabis derivative market creates confusion between CBD and psychoactive substances

The market for cannabis derivatives is becoming increasingly complex as products containing molecules like HHC and THC-P emerge. While CBD is known for its lack of significant psychoactive effects, these newer substances can produce intense psychoactive effects similar to traditional cannabis, often marketed under the guise of being legal.

This creates confusion for consumers who may find it difficult to distinguish between standard CBD and more potent cannabinoids. The European Union Drugs Agency has issued warnings regarding products that appear to be standard CBD but contain stronger cannabinoids. In Belgium, regulatory ambiguity persists as laws vary based on THC content and product form, such as oils, cosmetics, or edibles.

To ensure safety and avoid accidental psychoactive effects or failed drug tests, consumers are advised to seek high-quality CBD products guaranteed to be 0% THC. Using advanced extraction methods, professionals can provide products that allow users to work or drive without the risk of testing positive for THC.